UNSPSC 51283958: Sulfisomidine sodium

This classification denotes an anti-infective agent and sulfanilamide C12H13N4O2S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 296707F7DU, chemically known as sulfisomidine, sodium, but more generally known as sulfisomidine sodium, which bears US NIH Compound Identifier 5343. Most nations, for tariff and trade purposes, schedule sulfisomidine sodium under HS 29350090 and SITC 51580. As of Q4 2014, SULFISOMIDINE SODIUM remains US FDA's Preferred Term for this commodity. SMILES: CC1CC(NC(N1)C)[N-]S(=O)(=O)C2CCC(CC2)N.[NA+].

UNSPSC 51283958 Sulfisomidine sodium is a Commodity code that nominally covers a specific pharmaceutical active ingredient, yet the recent state and local opportunities tagged under it show no direct activity in that product. Instead, the opportunities reflect pharmaceutical procurement through cooperative purchasing vehicles and emergency-response health initiatives. State and local governments use codes in this family to acquire medications and pharmaceutical products for public health, emergency preparedness, and community health programs, typically through piggyback contracts with established consortiums or competitive bidding for specific therapeutic classes and quantities. The issuing bodies include state health departments and county health authorities pursuing both bulk pharmaceutical warehouse supplies and specialized emergency-response medications.

Illinois Department of Public Health awarded a piggyback contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026 (Solicitation 26482DPHPREPDB53392) for Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets totaling $2,999,999.11 over twelve months plus two renewal options, selected through an Invitation for Bid process as the lowest priced responsive and responsible bidder. Seminole County, Florida released an IFB (IFB60459723LAS) on June 30, 2026 with a July 26, 2023 response deadline seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, under a two-year initial term with one-year renewal option, potentially funded through FEMA. Recent activity concentrates in Florida and Illinois; the code shows limited scope alignment with its nominal product name and warrants closer review of actual procurement intent before pursuit.